Cargando…

Introducing cell-free DNA noninvasive testing in a Down syndrome public health screening program: a budget impact analysis

BACKGROUND: Non-invasive prenatal testing (NIPT) using cell-free fetal DNA in maternal plasma is a high accurate test for prenatal screening for Down syndrome. Although it has been reported to be cost effective as a contingent test, evidence about its budget impact is lacking. OBJECTIVE: To evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nshimyumukiza, L., Beaumont, J. A., Rousseau, F., Reinharz, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640422/ https://www.ncbi.nlm.nih.gov/pubmed/33292318 http://dx.doi.org/10.1186/s12962-020-00245-5

Ejemplares similares

Pregnant women's and policymakers' preferences for the expansion of noninvasive prenatal screening: A discrete choice experiment approach study
por: Nguyen, Hung Manh, et al.
Publicado: (2023)

Expansion of non-invasive prenatal screening to the screening of 10 types of chromosomal anomalies: a cost-effectiveness analysis
por: Soukkhaphone, Bounhome, et al.
Publicado: (2023)

Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador
por: Cremer, Miriam L., et al.
Publicado: (2016)

Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome
por: Xiao, Gefei, et al.
Publicado: (2022)

Noninvasive screening tools for Down syndrome: a review
por: Smith, Meagan, et al.
Publicado: (2013)

Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities
por: Gekas, Jean, et al.
Publicado: (2011)

Comparison of different strategies in prenatal screening for Down’s syndrome: cost effectiveness analysis of computer simulation
por: Gekas, Jean, et al.
Publicado: (2009)

Development of a discrete choice experiment questionnaire to elicit preferences by pregnant women and policymakers for the expansion of non-invasive prenatal screening
por: Nguyen, Hung Manh, et al.
Publicado: (2023)

Attitudes of Filipino parents of children with Down syndrome on noninvasive prenatal testing
por: de Castro-Hamoy, Leniza G., et al.
Publicado: (2022)

Public Budgeting in Context
por: Willoughby, Katherine
Publicado: (2014)

Inaccuracies and shortcomings in “Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations”
por: Johansen Taber, Katherine, et al.
Publicado: (2019)

Non‐invasive prenatal testing for the prenatal screening of sex chromosome aneuploidies: A systematic review and meta‐analysis of diagnostic test accuracy studies
por: Soukkhaphone, Bounhome, et al.
Publicado: (2021)

Correction: Inaccuracies and shortcomings in “Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations”
por: Taber, Katherine Johansen, et al.
Publicado: (2019)

Consequences of imprecision in fetal fraction estimation on performance of cell‐free DNA screening for Down syndrome
por: Persson, Fredrik, et al.
Publicado: (2022)

The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs
por: Giorgi Rossi, Paolo, et al.
Publicado: (2014)

Hemolysis and Fetal Fraction in Cell-Free DNA Blood Collection Tubes for Noninvasive Prenatal Testing
por: Stokowski, Renee, et al.
Publicado: (2020)

Budget Impact of the Accreditation Program for Clinical Laboratories on Colorectal Cancer Screening via Fecal Immunochemical Testing: Results from the National Cancer Screening Program in Korea
por: Jun, Jae Kwan, et al.
Publicado: (2018)

Cost‐effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point‐of‐care rapid test versus clinical judgment
por: Nshimyumukiza, Léon, et al.
Publicado: (2016)

Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis
por: Shang, Wenru, et al.
Publicado: (2021)

Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model
por: Nshimyumukiza, Léon, et al.
Publicado: (2013)

Public health and ethics: the case of prenatal screening and Down’s syndrome
por: Watson, Lorna
Publicado: (2020)

Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?
por: Hill, Melissa, et al.
Publicado: (2017)

Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests
por: Song, Le-Le, et al.
Publicado: (2016)

Advantages of the Quadruple Screen over noninvasive prenatal testing
por: Keller, Nathan A., et al.
Publicado: (2016)

Cell‐free DNA fetal fraction in twin gestations in single‐nucleotide polymorphism‐based noninvasive prenatal screening
por: Hedriana, Herman, et al.
Publicado: (2019)

Managing Healthcare Budgets in Times of Austerity: The Role of Program Budgeting and Marginal Analysis
por: Mitton, Craig, et al.
Publicado: (2014)

Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
por: Blom, Maartje, et al.
Publicado: (2018)

An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
por: Nshimyumukiza, Léon, et al.
Publicado: (2013)

Budget impact analysis of chronic kidney disease mass screening test in Japan
por: Kondo, Masahide, et al.
Publicado: (2014)

Women’s Attitudes Toward Invasive and Noninvasive Testing When Facing a High Risk of Fetal Down Syndrome
por: Seror, Valerie, et al.
Publicado: (2019)

Top–down assessment of the Asian carbon budget since the mid 1990s
por: Thompson, R. L., et al.
Publicado: (2016)

Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities
por: Bailey, James R., et al.
Publicado: (2016)

Budget Impact of Microbial Cell-Free DNA Testing Using the Karius(®) Test as an Alternative to Invasive Procedures in Immunocompromised Patients with Suspected Invasive Fungal Infections
por: MacIntyre, Ann T., et al.
Publicado: (2020)

Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand
por: Kositamongkol, Chayanis, et al.
Publicado: (2023)

Triple Test Screening for Down Syndrome: An Egyptian-Tailored Study
por: Abou-Youssef, Hazem S., et al.
Publicado: (2014)

Segmental Trisomy of Mouse Chromosome 17: Introducing an Alternative Model of Down’s Syndrome
por: Forejt, Jiri, et al.
Publicado: (2003)

Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy
por: Kim, Sunshin, et al.
Publicado: (2016)

Budget Impact of Introducing Linagliptin into Bosnia and Herzegovina Health Insurance Drug Reimbursement List in 2016-2018
por: Catic, Tarik, et al.
Publicado: (2017)

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries
por: Sauboin, Christophe, et al.
Publicado: (2019)

Budget impact of introducing once-every-6-months paliperidone palmitate in US health care plans
por: Phelps, Hilary, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_to20bgj6u9l95ckphf3e43k6pg